adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel
RxNorm concept 2668198, clinical drug (scd). Prescribable name: clindamycin phosphate 1.2 % / adapalene 0.15 % / benzoyl peroxide 3.1 % Topical Gel.
- RxCUI
- 2668198
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2668198 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
adapalene 0.15 % / benzoyl peroxide 3.1 % / clindamycin phosphate 1.2 % Topical Gel
Related concepts
- clindamycin phosphate 0.012 MG/MG (SCDC, consists of)
- adapalene 0.0015 MG/MG (SCDC, consists of)
- benzoyl peroxide 0.031 MG/MG (SCDC, consists of)
- Topical Gel (DF, has dose form)
- adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2668198 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2668198 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2668198. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.